MARKET

AXTN

AXTN

Akston Biosciences Corporation
AMEX
--
0.00
0.00%
Closed
OPEN
--
PREV CLOSE
--
HIGH
--
LOW
--
VOLUME
0
TURNOVER
--
52 WEEK HIGH
--
52 WEEK LOW
--
MARKET CAP
--
P/E (TTM)
--
1D
5D
1M
3M
1Y
5Y
1D
No Data
About AXTN
Akston Biosciences Corporation is a United States-based pet biotechnology company. The Company focuses on the development and commercialization of biopharmaceutical products for cats, dogs, and other companion animals. Its product portfolio includes multiple product candidates consisting of large molecule biologics that are designed to target medical conditions in pets such as urothelial carcinoma (bladder cancer) in dogs, atopic dermatitis in dogs, chronic pain associated with arthritis in dogs, and obesity and metabolic disease in cats. Its pipeline includes AKS-701d (Monoclonal Antibody), AKS-619d (Ambifect Immuno enhancing Protein), AKS-562c (Targeted Precision Protein), and others. Its Ambifect technology platform is designed to harness the animal’s own cells to produce therapeutic levels of targeted antibodies, leveraging the immune system to sustain long-term antibody production through simple intramuscular injections.

Webull offers Akston Biosciences Corporation stock information, including AMEX: AXTN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AXTN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AXTN stock methods without spending real money on the virtual paper trading platform.